1. Home
  2. CASY vs UTHR Comparison

CASY vs UTHR Comparison

Compare CASY & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casey's General Stores Inc.

CASY

Casey's General Stores Inc.

HOLD

Current Price

$562.62

Market Cap

21.1B

Sector

Miscellaneous

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$495.27

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASY
UTHR
Founded
1959
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
20.3B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
CASY
UTHR
Price
$562.62
$495.27
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$581.10
$495.08
AVG Volume (30 Days)
318.8K
469.0K
Earning Date
12-09-2025
10-29-2025
Dividend Yield
0.40%
N/A
EPS Growth
13.31
16.08
EPS
16.25
26.38
Revenue
$16,969,580,999.00
$3,128,400,000.00
Revenue This Year
$10.48
$13.64
Revenue Next Year
$5.60
$5.78
P/E Ratio
$34.89
$19.07
Revenue Growth
13.33
13.50
52 Week Low
$372.09
$266.98
52 Week High
$575.98
$519.99

Technical Indicators

Market Signals
Indicator
CASY
UTHR
Relative Strength Index (RSI) 53.03 52.94
Support Level $541.12 $498.76
Resistance Level $575.97 $519.99
Average True Range (ATR) 13.89 10.91
MACD 0.73 -1.69
Stochastic Oscillator 69.85 43.56

Price Performance

Historical Comparison
CASY
UTHR

About CASY Casey's General Stores Inc.

Casey's General Stores Inc serves as convenience store chain with its 2,900 locations, positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two-thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates the majority of its warehousing and distribution processes internally.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: